Rod J. Flower

Articles in Scholarly Journals [Incomplete List]

  1. Role of annexin 1 gene expression in mouse craniofacial bone development
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 79, no. 7, pp. 524–532, 2007
  2. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation
    The FASEB Journal, vol. 21, no. 8, pp. 1751–1758, 2007
  3. Antiflammin-2 Activates the Human Formyl-Peptide Receptor Like 1
    TheScientificWorldJOURNAL, vol. 6, pp. 1375–1384, 2006
  4. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface
    The FASEB Journal, vol. 20, no. 9, pp. 1498–1500, 2006
  5. Lack of Annexin 1 Results in an Increase in Corticotroph Number in Male but not Female Mice
    Journal of Neuroendocrinology, vol. 18, no. 11, pp. 835–846, 2006
  6. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement
    Blood, vol. 107, no. 5, pp. 2123–2130, 2006
  7. Annexin-1 modulates T-cell activation and differentiation
    Blood, vol. 109, no. 3, pp. 1095–1102, 2006
  8. Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue
    AJP: Endocrinology and Metabolism, vol. 291, no. 6, pp. E1264–E1273, 2006
  9. Annexin 1, Glucocorticoids, and the Neuroendocrine-Immune Interface
    Annals of the New York Academy of Sciences, vol. 1088, no. 1, pp. 396–409, 2006
  10. Prostaglandins, bioassay and inflammation
    British Journal of Pharmacology, vol. 147, Article ID 0706506, 2006
  11. Impaired phagocytic mechanism in annexin 1 null macrophages
    British Journal of Pharmacology, vol. 148, no. 4, Article ID 0706730, 8 pages, 2006
  12. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro
    Journal of Leukocyte Biology, vol. 78, no. 3, pp. 639–646, 2005
  13. Ligand-specific glucocorticoid receptor activation in human platelets
    Blood, vol. 106, no. 13, pp. 4167–4175, 2005
  14. A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the Rat
    Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 3, pp. 1416–1422, 2005
  15. Controlling inflammation: a fat chance?
    Journal of Experimental Medicine, vol. 201, no. 5, pp. 671–674, 2005
  16. Macrophage biology in the Anx-A1 mouse
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 72, no. 2, pp. 95–103, 2005
  17. Annexin 1 and the regulation of endocrine function
    Trends in Endocrinology and Metabolism, vol. 15, no. 3, pp. 103–109, 2004
  18. Lifestyle drugs: pharmacology and the social agenda
    Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 182–185, 2004
  19. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis
    Arthritis & Rheumatism, vol. 50, no. 3, pp. 976–984, 2004
  20. Annexin 1 and the biology of the neutrophil
    Journal of Leukocyte Biology, vol. 76, no. 1, pp. 25–29, 2004
  21. Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages
    British Journal of Pharmacology, vol. 142, no. 5, Article ID 0705858, 8 pages, 2004
  22. Attenuation of glucocorticoid functions in an Anx-A1-/- cell line
    Biochemical Journal, vol. 371, no. 3, p. 927, 2003
  23. Kinase-Dependent Regulation of the Secretion of Thyrotrophin and Luteinizing Hormone By Glucocorticoids and Annexin 1 Peptides
    Journal of Neuroendocrinology, vol. 15, no. 10, pp. 946–957, 2003
  24. Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids
    Digestive and Liver Disease, vol. 35, pp. S41–S48, 2003
  25. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms
    Blood, vol. 101, no. 10, pp. 4140–4147, 2003
  26. Dexamethasone Induces Rapid Serine-Phosphorylation and Membrane Translocation of Annexin 1 in a Human Folliculostellate Cell Line via a Novel Nongenomic Mechanism Involving the Glucocorticoid Receptor, Protein Kinase C, Phosphatidylinositol 3-Kinase, and Mitogen-Activated Protein Kinase
    Endocrinology, vol. 144, no. 4, pp. 1164–1174, 2003
  27. What are all the things that aspirin does?
    BMJ, vol. 327, no. 7415, pp. 572–573, 2003
  28. Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system
    Cell Biochemistry and Function, vol. 21, no. 3, pp. 217–221, 2003
  29. Studies on the mechanism of action of anti-inflammatory drugs A paper in honour of John Vane
    Thrombosis Research, vol. 110, no. 5-6, pp. 259–263, 2003
  30. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis
    Arthritis & Rheumatism, vol. 46, no. 10, pp. 2765–2775, 2002
  31. Annexin 1-Dependent Actions of Glucocorticoids in the Anterior Pituitary Gland: Roles of the N-Terminal Domain and Protein Kinase C
    Endocrinology, vol. 143, no. 8, pp. 3060–3070, 2002
  32. Drug receptors: A long engagement
    Nature, vol. 415, no. 6872, pp. 587–587, 2002
  33. Medicine: Lipid signals in pain control
    Nature, vol. 420, no. 6912, Article ID 420135a, 3 pages, 2002
  34. Complete coding sequence of equine inducible nitric oxide synthase
    Research in Veterinary Science, vol. 72, no. 3, p. 245, 2002
  35. Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis
    Proceedings of the National Academy of Sciences, vol. 99, no. 3, pp. 1677–1682, 2002
  36. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice
    Proceedings of the National Academy of Sciences, vol. 99, no. 24, pp. 15770–15775, 2002
  37. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells
    British Journal of Pharmacology, vol. 135, no. 2, Article ID 0704474, 8 pages, 2002
  38. Opposing influences of glucocorticoids and interleukin-1ß on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1
    British Journal of Pharmacology, vol. 134, no. 4, Article ID 0704324, 8 pages, 2001
  39. Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study
    British Journal of Haematology, vol. 113, no. 2, pp. 514–520, 2001
  40. Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1
    Clinical and Experimental Immunology, vol. 123, no. 1, pp. 62–67, 2001
  41. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action
    The FASEB Journal, vol. 15, no. 12, pp. 2247–2256, 2001
  42. Analysis of the protection afforded by annexin 1 in ischaemia–reperfusion injury: focus on neutrophil recruitment
    European Journal of Pharmacology, vol. 429, no. 1-3, pp. 263–278, 2001
  43. Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I)
    Life Sciences, vol. 66, no. 18, pp. PL265–PL270, 2000
  44. ANNEXIN I IS STORED WITHIN GELATINASE GRANULES OF HUMAN NEUTROPHIL AND MOBILIZED ON THE CELL SURFACE UPON ADHESION BUT NOT PHAGOCYTOSIS
    Cell Biology International, vol. 24, no. 3, pp. 163–174, 2000
  45. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism
    British Journal of Pharmacology, vol. 130, no. 2, Article ID 0703272, 9 pages, 2000
  46. Investigation into the involvement of phospholipases A2 and MAP kinases in modulation of AA release and cell growth in A549 cells
    British Journal of Pharmacology, vol. 131, no. 2, Article ID 0703573, 10 pages, 2000
  47. Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1)
    British Journal of Pharmacology, vol. 131, no. 7, Article ID 0703694, 7 pages, 2000
  48. 21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties
    British Journal of Pharmacology, vol. 131, no. 7, Article ID 0703704, 9 pages, 2000
  49. Contrasting roles for RANTES and macrophage inflammatory protein-1alpha (MIP-1alpha) in a murine model of allergic peritonitis
    Clinical and Experimental Immunology, vol. 117, no. 2, pp. 223–229, 1999
  50. Non-steroidal anti-inflammatory drugs: back to the future
    Rheumatology, vol. 38, no. 8, pp. 693–696, 1999
  51. Differential modulation of annexin I binding sites on monocytes and neutrophils
    Mediators of Inflammation, vol. 8, no. 1, pp. 53–62, 1999
  52. Localisation and Semi-Quantitative Measurement Of Lipocortin 1 In Rat Anterior Pituitary Cells By Fluorescence-Activated Cell Analysis/Sorting and Electron Microscopy
    Journal of Neuroendocrinology, vol. 11, no. 9, pp. 707–714, 1999
  53. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1
    Proceedings of the National Academy of Sciences, vol. 95, no. 24, pp. 14535–14539, 1998
  54. Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation
    Immunology, vol. 95, no. 4, pp. 625–630, 1998
  55. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E-Q-E-Y-V as a crucial component
    British Journal of Pharmacology, vol. 123, no. 5, Article ID 0701679, 8 pages, 1998
  56. Investigation of the functional role played by the chemokine monocyte chemoattractant protein-1 in interleukin-1-induced murine peritonitis
    British Journal of Pharmacology, vol. 125, no. 2, Article ID 0702071, 7 pages, 1998
  57. IL-6 STIMULATES ANNEXIN 1 EXPRESSION AND TRANSLOCATION AND SUGGESTS A NEW BIOLOGICAL ROLE AS CLASS II ACUTE PHASE PROTEIN
    Cytokine, vol. 10, no. 7, pp. 514–521, 1998
  58. Blockade of the classical pathway of protein secretion does not affect the cellular exportation of lipocortin 1
    Regulatory Peptides, vol. 73, no. 2, pp. 133–139, 1998
  59. Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1401, no. 1, pp. 39–51, 1998
  60. Suppression by Dexamethasone of Inducible Nitric Oxide Synthase Protein Expression In Vivo A Possible Role for Lipocortin 1
    Biochemical Pharmacology, vol. 55, no. 3, pp. 279–285, 1998
  61. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis
    Molecular Medicine Today, vol. 3, no. 7, pp. 296–302, 1997
  62. Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1349, no. 3, pp. 275–284, 1997
  63. Subacute Treatment of Rats with Dexamethasone Reduces ICAM-1 Levels on Circulating Monocytes
    Biochemical and Biophysical Research Communications, vol. 231, no. 3, pp. 675–678, 1997
  64. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1
    British Journal of Pharmacology, vol. 120, no. 6, Article ID 0701029, 7 pages, 1997
  65. A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment
    British Journal of Pharmacology, vol. 121, no. 1, Article ID 0701122, 7 pages, 1997
  66. Effects of dexamethasone and phorbol ester on P2 receptor-coupled Ca2+ signalling and lipocortin 1 presentation in U937 cells
    British Journal of Pharmacology, vol. 122, no. 6, Article ID 0701490, 5 pages, 1997
  67. Dexamethasone reduces cell surface levels of CD11b on human eosinophils
    Mediators of Inflammation, vol. 6, no. 5-6, pp. 363–367, 1997
  68. Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects
    Journal of Experimental Medicine, vol. 186, no. 7, pp. 1041–1049, 1997
  69. An Antisense Oligodeoxynucleotide to Lipocortin 1 Reverses the Inhibitory Actions of Dexamethasone on the Release of Adrenocorticotropin from Rat Pituitary Tissue in Vitro
    Endocrinology, vol. 138, no. 7, pp. 2909–2918, 1997
  70. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration
    Nature Medicine, vol. 2, no. 11, Article ID nm1196-1259, 3 pages, 1996
  71. The Concerted Regulation of cPLA, COX2, and Lipocortin 1 Expression by IL-1ß in A549 Cells
    Biochemical and Biophysical Research Communications, vol. 220, no. 3, pp. 491–495, 1996
  72. Relative Contribution of the Selectins in the Neutrophil Recruitment Caused by the Chemokine Cytokine-Induced Neutrophil Chemoattractant (CINC)
    Biochemical and Biophysical Research Communications, vol. 221, no. 3, pp. 692–696, 1996
  73. Modulation of ICAM-1 Levels on U-937 Cells and Mouse Macrophages by Interleukin-1ß and Dexamethasone
    Biochemical and Biophysical Research Communications, vol. 223, no. 1, pp. 112–117, 1996
  74. Relative Contribution of the Selectins in the Neutrophil Recruitment Caused by the Chemokine Cytokine-Induced Neutrophil Chemoattractant (CINC) Volume221,Number 3 (1996), pages 692–696
    Biochemical and Biophysical Research Communications, vol. 224, no. 3, pp. 878–879, 1996
  75. Effect of interleukin-1ß on the release of substance P from rat isolated spinal cord
    European Journal of Pharmacology, vol. 299, no. 1-3, pp. 113–118, 1996
  76. Functional importance of the dihydropyridine-sensitive, yet voltage-insensitive store-operated Ca2+ influx of U937 cells
    FEBS Letters, vol. 394, no. 2, pp. 159–164, 1996
  77. Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide
    European Journal of Pharmacology, vol. 279, no. 2-3, pp. 149–157, 1995
  78. Endogenous corticosteroids mediate the neutrophilia caused by platelet-activating factor in the mouse
    European Journal of Pharmacology, vol. 283, no. 1-3, pp. 9–18, 1995
  79. Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1
    European Journal of Pharmacology, vol. 283, no. 1-3, pp. 193–198, 1995
  80. Lipocortin-1 and the control of arachidonic acid release in cell signalling Glucorticoids inhibit G protein-dependent activation of cPLA2 activity
    Biochemical Pharmacology, vol. 50, no. 4, pp. 465–474, 1995
  81. Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus
    Biochemical Pharmacology, vol. 50, no. 7, pp. 1037–1042, 1995
  82. Lipocortin 1 Mediates the Inhibition by Dexamethasone of the Induction by Endotoxin of Nitric Oxide Synthase in the Rat
    Proceedings of the National Academy of Sciences, vol. 92, no. 8, pp. 3473–3477, 1995
  83. Induction of lipocortin 1 by topical steroid in rat skin
    Biochemical Pharmacology, vol. 48, no. 8, pp. 1647–1654, 1994
  84. Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release
    Biochemical Pharmacology, vol. 48, no. 9, pp. 1729–1734, 1994
  85. Differential role of extra- and intracellular calcium in bradykinin and interleukin 1a stimulation of arachidonic acid release from A549 cells
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1211, no. 3, pp. 301–309, 1994
  86. Dexamethasone Suppression of IL-1ß-Induced Cyclooxygenase 2 Expression Is Not Mediated by Lipocortin-1 in A549 Cells
    Biochemical and Biophysical Research Communications, vol. 202, no. 2, pp. 931–939, 1994
  87. Lipocortin-1: cellular mechanisms and clinical relevance
    Trends in Pharmacological Sciences, vol. 15, no. 3, pp. 71–76, 1994
  88. Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis
    Journal of the Neurological Sciences, vol. 119, no. 2, pp. 146–153, 1993
  89. N-terminal peptide fragments of lipocortin-1 inhibit a549 cell growth and block EGF-induced stimulation of proliferation
    International Journal of Cancer, vol. 54, no. 1, pp. 153–158, 1993
  90. The Ability of Murine Leukocytes to Bind Lipocortin 1 Is Lost during Acute Inflammation
    Biochemical and Biophysical Research Communications, vol. 192, no. 2, pp. 345–350, 1993
  91. Phospholipase A2-induced stimulation of A549 lung adenocarcinoma cell line proliferation
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1169, no. 3, pp. 236–242, 1993
  92. Effect of chronic capsaicin and guanethidine treatment on skin blood flow of the rat
    Agents and Actions, vol. 38, no. S2, pp. C16–C18, 1993
  93. Pharmacology of interleukin-1-induced neutrophil migration
    Agents and Actions, vol. 38, no. S2, pp. C64–C65, 1993
  94. Effects of Lipocortin 1 and Dexamethasone on the Secretion of Corticotrophin-Releasing Factors in the Rat: in vitro and in vivo Studies
    Journal of Neuroendocrinology, vol. 5, no. 1, pp. 51–61, 1993
  95. Correction: Lipocortin 1 Mediates Dexamethasone-Induced Growth Arrest of the A459 Lung Adenocarcinoma Cell Line
    Proceedings of the National Academy of Sciences, vol. 89, no. 17, pp. 8408–8408, 1992
  96. Lipocortin 1 Mediates Dexamethasone-Induced Growth Arrest of the A549 Lung Adenocarcinoma Cell Line
    Proceedings of the National Academy of Sciences, vol. 89, no. 8, pp. 3571–3575, 1992
  97. Evidence for the presence and location of annexins in human platelets
    Biochemical and Biophysical Research Communications, vol. 189, no. 3, pp. 1739–1746, 1992
  98. Site of anti-inflammatory action of dexamethasone in rabbit skin
    European Journal of Pharmacology, vol. 196, no. 1, pp. 37–41, 1991
  99. Circulating autoantibodies to recombinant lipocortin-1 in asthma
    Respiratory Medicine, vol. 85, no. 2, pp. 121–124, 1991
  100. The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis
    British Journal of Dermatology, vol. 123, no. 5, pp. 569–572, 1990
  101. Human Recombinant Lipocortin 1 Has Acute Local Anti-Inflammatory Properties in the Rat Paw Edema Test
    Proceedings of the National Academy of Sciences, vol. 86, no. 9, pp. 3428–3432, 1989
  102. A study of phospholipase A2-induced oedema in rat paw
    European Journal of Pharmacology, vol. 166, no. 3, pp. 505–510, 1989
  103. The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat
    Life Sciences, vol. 45, no. 1, pp. 97–104, 1989
  104. Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486
    Biochemical Pharmacology, vol. 37, no. 3, pp. 556–557, 1988
  105. A novel binding assay for phospholipase A2
    Biochemical Pharmacology, vol. 36, no. 24, pp. 4287–4291, 1987
  106. Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery ? ?
    Prostaglandins, vol. 34, no. 1, pp. 59–62, 1987
  107. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung
    Nature, vol. 328, no. 6127, Article ID 328270a0, 2 pages, 1987
  108. Inflammation: The mediators of steroid action
    Nature, vol. 320, no. 6057, Article ID 320020a0, 1 pages, 1986
  109. Background and discovery of lipocortins
    Agents and Actions, vol. 17, no. 3-4, pp. 255–262, 1986
  110. The effect of glucocorticoids on lyso-PAF formationin vitro andin vivo
    Agents and Actions, vol. 17, no. 3-4, pp. 312–313, 1986
  111. Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes
    Life Sciences, vol. 36, no. 13, pp. 1225–1231, 1985
  112. Anti-phospholipase proteins
    Prostaglandins, vol. 28, no. 4, pp. 441–442, 1984
  113. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins
    European Journal of Pharmacology, vol. 99, no. 2-3, pp. 233–239, 1984
  114. Measuring platelet and leucocyte aggregation/adhesion responses in very small volumes of whole blood
    Journal of Pharmacological Methods, vol. 6, no. 4, pp. 315–333, 1981
  115. The electronic aggregometer: A novel device for assessing platelet behavior in blood
    Journal of Pharmacological Methods, vol. 3, no. 2, pp. 135–158, 1980
  116. A new approach to anti-inflammatory drugs
    Biochemical Pharmacology, vol. 28, no. 12, pp. 1959–1961, 1979
  117. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation
    Nature, vol. 278, no. 5703, Article ID 278456a0, 3 pages, 1979
  118. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes
    Biochimica et Biophysica Acta (BBA) - Enzymology, vol. 523, no. 1, pp. 250–262, 1978
  119. The effect of bradykinin on the electrical activity of rat jejunum
    Experientia, vol. 34, no. 5, pp. 617–618, 1978
  120. 1-phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets
    Prostaglandins, vol. 16, no. 3, pp. 417–425, 1978
  121. Synthesis of 6-keto-PGF1a by ram seminal vesicle microsomes
    Prostaglandins, vol. 14, no. 3, pp. 413–423, 1977
  122. The importance of phospholipase-A2 in prostaglandin biosynthesis
    Biochemical Pharmacology, vol. 25, no. 3, pp. 285–291, 1976
  123. Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism
    Nature, vol. 260, no. 5552, Article ID 260582a0, 4 pages, 1976
  124. Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids
    Nature, vol. 263, no. 5577, Article ID 263479a0, 3 pages, 1976
  125. On the design of a circularly polarized waveguide narrow wall linear array
    IEEE Transactions on Antennas and Propagation, vol. 23, no. 2, pp. 244–250, 1975
  126. Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 398, no. 1, pp. 178–190, 1975
  127. A simple isotope derivative assay for prostaglandins and prostaglandin metabolites I. Assay of E-type prostaglandins
    Analytical Biochemistry, vol. 68, no. 2, pp. 436–447, 1975
  128. Inhibition of prostaglandin biosynthesis
    Biochemical Pharmacology, vol. 23, no. 10, pp. 1439–1450, 1974
  129. Reduction of the inflammatory response in rats immunized against prostaglandins
    Prostaglandins, vol. 8, no. 5, pp. 433–437, 1974
  130. Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle
    Prostaglandins, vol. 4, no. 3, pp. 325–341, 1973
  131. Aspirin-like drugs and prostaglandins
    American Heart Journal, vol. 86, no. 6, pp. 844–846, 1973
  132. Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)
    Nature, vol. 240, no. 5381, Article ID 240410a0, 1 pages, 1972
  133. EFFECT OF ASPIRIN ON HUMAN SEMINAL PROSTAGLANDINS
    The Lancet, vol. 298, no. 7729, pp. 852–853, 1971